
Crisil Ratings Updates Anupam Rasayan India Ltd; Assigns A+/Watch for Debentures
Anupam Rasayan India Limited (ARIL) received a rating update from Crisil Ratings Limited concerning its corporate profile and debt instruments. The ratings reflect the company's established market position, diversification efforts, and ongoing operational challenges amid significant revenue growth in the chemicals sector.Crisil Ratings assigned specific ratings for ARIL's long term and short term facilities, as well as for non-convertible debentures (NCD), after reviewing the company's financial stability and business risk profile. The agency also noted an enhancement to the total bank loan facilities under review.
The key rating metrics provided by Crisil Ratings are detailed below:
| Metric | Rating Status |
|---|---|
| Long Term Rating (LTL) | Crisil A+/Watch Developing |
| Short Term Rating | Crisil A1/Watch Developing |
| Non-Convertible Debentures (NCD) | Crisil A+/Watch Developing |
ARIL's Total Bank Loan Facilities rated have been enhanced to Rs 1620 Crore, up from the previously rated amount of Rs 1369.82 Crore. The NCD rating was assigned against an issue size of Rs 160 Crore.
Financial Performance and Operational Trends
The ratings assessment included a review of ARIL's recent financial performance. Revenue for ARIL reached Rs 2,365 crore in fiscal 2026, showing a substantial increase from Rs 1,439 crore recorded in fiscal 2025.However, the company saw its operating margin decline to 22.19% in fiscal 2026, compared to 27.67% in fiscal 2025, which was attributed to the limited ability to pass on higher costs. Despite this, key operational efficiencies improved, with inventory days falling from 510 days as of March 31, 2025, to 324 days as of March 31, 2026. Similarly, receivables decreased from 190 days to 148 days over the same period.
Strategic Drivers and Risk Analysis
Crisil Ratings evaluated ARIL based on the operational strength and financial risk profile of the entire Anupam Rasayan group, which includes subsidiaries like Jainam Intermediates Pvt Ltd, Aril Transmodal Logistic Pvt Ltd, and Anupam Europe AG.Key Strengths:
The company benefits from a strong market position in custom synthesis and specialty chemicals, supported by integrated operations and robust clientele across 31 multinationals and 75 clients. Furthermore, ARIL's diversification has increased the contribution of the pharma and polymer segments to over 30% of revenue in fiscal 2026.
A critical strategic move noted by Crisil Ratings was ARIL's acquisition of Tanfac Industries Ltd, a producer of hydrogen fluoride and potassium fluoride, which are vital raw materials for fluorinated molecules used in agrochemicals and polymers. This acquisition ensures an uninterrupted supply of these inputs. The company maintained healthy financial risk indicators, with the Total Outside Liabilities to Adjusted Net Worth (TOLANW) ratio standing at 0.78 time as on March 31, 2026.
Areas of Concern:
The ratings also highlighted operational challenges, including working capital intensive operations and susceptibility to global economic downturns or raw material price volatility. The company generates over 50% of its revenue from exports to European and North American markets.
Liquidity remains strong, supported by cash and equivalent holdings exceeding Rs 378 crore as on March 31, 2026.
Financial Indicators Summary
| Indicator | FY 2026 (Rs crore) | FY 2025 (Rs crore) |
|---|---|---|
| Revenue | 2365.46 | 1438.72 |
| Reported Profit After Tax (PAT) | 222.20 | 159.85 |
| PAT Margin | 9.39% | 11.11% |
| Adjusted Debt / Adjusted Networth | 0.54 times | 0.45 times |
ANURAS Stock Price Movement
As of 1:47 PM, Anupam Rasayan India Limited's shares are slipping by 0.22% in live trading, currently priced at ₹1322.00. The stock saw a total traded volume of 145,518 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.